Point of Care Diagnostics for Lead Testing
Lead exposure remains a critical but under-addressed public health challenge. Approximately 1 in 3 children globally have toxic levels of lead in their bloodstream, leading to developmental delays, cognitive impairment, and increased risk of chronic diseases. However, as it stands most countries do not do comprehensive, routine surveillance of blood lead levels. This is because the primary method for blood lead surveillance is costly and inconvenient.
Resources (1)
Lead, Roadmaps, and 800M Children
Whitepapers and Essays
R&D Gaps (1)
Current diagnostic tests are costly or often offer only limited information, failing to reveal the cause of disease and delaying or preventing administration of available treatments. Moreover, early detection systems for emerging pathogens are fragmented, delaying critical public health intervention...